Ligand Pharmaceuticals Inc
SWB:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Ligand Pharmaceuticals Inc (LGDN) under the Base Case is EUR per share.
Compared with the current market price of 280 EUR, the stock appears .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What Ligand Pharmaceuticals Does
Ligand Pharmaceuticals is a biotech company that makes money mainly by licensing drug-development technologies to other drugmakers. It does not sell drugs directly to patients. Instead, it helps pharmaceutical and biotech partners create and improve medicines through tools such as formulation know-how and protein-based discovery platforms, then earns fees, milestones, and royalties tied to those partnered products.
- Headquarters
- United States of America US
- Employees
- 47
- IPO date
- Nov 18, 1992
Ownership
Ligand Pharmaceuticals insiders are selling more than usual
Insiders sell for many reasons, such as taxes or planned sales; purchases are rarer.
Continue LGDN Research
Decided on Ligand Pharmaceuticals? Get an email when LGDN reaches the price you’d buy at. Free with an account.
Other Ligand Pharmaceuticals listings
What is the Intrinsic Value of one LGDN stock?
The intrinsic value for
Ligand Pharmaceuticals Inc (LGDN) under the Base Case is EUR.
Is LGDN stock undervalued or overvalued?
Compared with the current market price of 280 EUR, the stock appears .